Navigation Links
Brain study offers insight into causes of autism
Date:2/11/2010

Scientists are a step closer to understanding how abnormalities in brain development might lead to autism and behavioural disorders.

Research into Fragile X Syndrome a genetic condition that is the leading known cause of autism has discovered that critical phases in the brain's development may be mistimed in people with the condition.

The mistiming of key developmental stages may result in inappropriate communication between brain cells and could cause the symptoms experienced by Fragile X patients, such as hypersensitivity to touch and sound, as well as social withdrawal, hyperactivity and anxiety.

The study also found these changes in the brain's connections occur much earlier than previously thought, midway through a baby's development in the womb.

Scientists say that the study, published in the journal Neuron, suggests there are key "windows" when treatments for Fragile X and autism could be most effective.

Fragile X syndrome is as common as cystic fibrosis it affects around one in 4000 males and one in 8000 females worldwide. It causes intellectual disability as well as social, language and behavioural problems.

The research, conducted by scientists at Northwestern University in the USA and the University of Edinburgh, sought to identify ways in which the brains of people with Fragile X differ from those of healthy people.

Researchers used a mouse model of the condition to investigate how the regions of the brain responsible for processing sensory information for example, touch may develop differently in Fragile X patients.

The team believes that the changes they found in this area of the brain may be mirrored in other regions, explaining the range of symptoms experienced by people with Fragile X syndrome.

Professor Peter Kind, who led the study at the University of Edinburgh, said: "This research is important because it indicates when changes take place in the
'/>"/>

Contact: Anna Borthwick
anna.borthwick@ed.ac.uk
44-131-651-4400
University of Edinburgh
Source:Eurekalert

Page: 1 2

Related biology news :

1. Invasion of the brain tumors
2. HIV is a double hit to the brain
3. AIDS interferes with stem cells in the brain
4. 60 second test could help early diagnosis of common brain diseases
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Influence of sex and handedness on brain is similar in capuchin monkeys and humans
8. Inside the brain of a crayfish
9. Specific brain protein required for nerve cell connections to form and function
10. Brains timing linked with timescales of the natural visual world
11. Adult brain can change, study confirms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 2015. The new marketing campaign is being spearheaded by ... Group ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... retail driven marketing and brand awareness and has a ...
(Date:8/11/2015)... 11, 2015 Today, ZUK announced its Android ... well as expected revenues in 2015 that relate to sales of ... guidance of approximately 2,200 MSEK for 2015. Jörgen Lantto, ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... 6, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced collaboration with Microsoft on biometric ... Microsoft leveraged Synaptics, deep expertise in human interface ... Through stringent testing, Synaptics, advanced image ... Microsoft,s Precision TouchPad (PTP) specification empowering OEMs with ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... latest American Chemical Society (ACS) Weekly PressPac from the ... 34 peer-reviewed journals and Chemical & Engineering News.,Please credit ... the source for this information. PressPac Archive: ... 1 FOR IMMEDIATE RELEASE, Solving the mystery of what ...
... (April 12, 2009) In certain respects, cells are ... have lots of components, but they also have lots ... are studied in aggregate (conservatives, liberals, atheists, evangelicals), they ... looked at one person at a time, individuals often ...
... a result of exposure to ionizing radiation, they must make ... for death, a process called apoptosis. It,s a ... involving what might be described metaphorically as a network of ... the cell nucleus. In intricate ways, cells orchestrate a ...
Cached Biology News:American Chemical Society Weekly PressPac -- April 8, 2009 2American Chemical Society Weekly PressPac -- April 8, 2009 3American Chemical Society Weekly PressPac -- April 8, 2009 4American Chemical Society Weekly PressPac -- April 8, 2009 5American Chemical Society Weekly PressPac -- April 8, 2009 6American Chemical Society Weekly PressPac -- April 8, 2009 7American Chemical Society Weekly PressPac -- April 8, 2009 8American Chemical Society Weekly PressPac -- April 8, 2009 9American Chemical Society Weekly PressPac -- April 8, 2009 10American Chemical Society Weekly PressPac -- April 8, 2009 11For cancer cells, genetics alone is poor indicator for drug response 2For cancer cells, genetics alone is poor indicator for drug response 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 2CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 3CSHL-led team identifies key decision-point at which cells with broken DNA repair themselves or die 4
(Date:8/27/2015)... , Aug. 27, 2015  Neogen Corporation (NASDAQ: ... stock of United Kingdom -based Lab ... culture media and diagnostic systems. Lab ... a leading provider of microbial testing and diagnostic products ... markets. The company currently sells into more than 70 ...
(Date:8/27/2015)... GUELPH, ON , Aug. 27, 2015 /PRNewswire/ - BIOREM Inc. ... the three and six-month periods ended June 30, 2015. Biorem,s complete ... ( www.sedar.com ). FINANCIAL HIGHLIGHTS: in ,000,s except earnings per ... , 2014 , 2015 , ... 9,398 , 4,433 Gross profit , 1,656 ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... needs and expertly narrows down the product choices to a manageable shortlist of ... down the list to models that fit best with the customer’s industry and ...
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
Breaking Biology Technology:Neogen acquires U.K.-based Lab M Holdings 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3METTLER TOLEDO Updates Online Scale Selection Tool 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3
... -Now for Exclusion of Venous Thromboembolism-, LEXINGTON, ... that the US Food and Drug Administration (FDA) ... for the HemosIL D-Dimer,assay to exclude venous thromboembolism ... and pulmonary embolism (PE), when used in,conjunction with ...
... Performance - Net Profit Up 16.8% at Constant Exchange Rates - Essilor Launches a Share Buyback Program ... the six months,ended June 30, 2008., EUR millions First-half 2008 ... ... at constant ...
... UK,s National Physical Laboratory (NPL) to survey nanotechnology capabilities ... to identify the next generation of nano and smart ... , "Advances in nanotechnology are crucial to Europe,s space ... nanomaterials group at NPL, who will be the principal ...
Cached Biology Technology:Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay 2Essilor's First-Half 2008 Results 2Essilor's First-Half 2008 Results 3Essilor's First-Half 2008 Results 4Essilor's First-Half 2008 Results 5Essilor's First-Half 2008 Results 6Essilor's First-Half 2008 Results 7Essilor's First-Half 2008 Results 8